首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1463115

催產素市場,佔有率,規模,趨勢,行業分析報告：依適應症、依分銷管道、依地區、依細分市場、預測，2024-2032 年

Oxytocin Market Share, Size, Trends, Industry Analysis Report, By Indication (Antepartum, Postpartum), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2032

出版日期: 2024年03月24日 | 出版商:

Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

根據Polaris Market Research最新研究顯示，預計到2032年，全球催產素市場規模將達到1.9302億美元。該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

由於優先考慮安全有效的產科護理的孕產婦保健措施的增加，市場正在成長。催產素對於引產和控制產後出血至關重要，在孕產婦保健中發揮至關重要的作用。降低孕產婦死亡率、加強獲得優質醫療保健和改善產科護理的努力促使對催產素注射的需求增加。此外，確保孕產婦保健計劃中基本藥物供應的努力正在推動市場，特別是在面臨重大孕產婦保健課題的地區，在加強孕產婦結局和產科護理方面，人們強調催產素發揮著重要作用。

剖腹產分娩的日益普及正在推動市場的發展。這是因為催產素在擇期剖腹產和緊急剖腹產期間促進或開始分娩方面發揮著重要作用。全球剖腹產數量的增加增加了注射催產素以引產和誘導術後子宮收縮的需求。催產素對於預防產後出血和促進剖腹產期間的安全分娩至關重要。

催產素在預防和控制 PPH（死亡的主要原因）方面發揮著至關重要的作用。提高醫療保健提供者和政策制定者對注射催產素以控制過度出血的救生作用的認識。強調預防產後出血重要性的孕產婦保健計劃、運動和健康倡議將進一步刺激催產素注射的採用。由於催產素在預防產後出血中的作用，醫療保健系統正在幫助降低死亡率。

催產素市場報告亮點

由於孕產婦死亡率和併發症的增加，產後市場所佔佔有率最大

醫院部門由於醫療設備齊全，在市場上佔據主導地位。

由於出生人數的增加和孕產婦健康意識的提高，亞太地區預計將成長最快

主要市場參與者包括Pfizer, Novartis, Ferring, Fresenius Kabi, Hikma Pharmaceuticals, Endo International, Sun Pharmaceuticals, Yuhan Corporation。

主要發現
介紹
- 催產素市場評估，依地區，2019-2032
催產素市場 - 北美
- 北美：催產素市場，依通路劃分，2019-2032
- 北美：催產素市場，依適應症分類，2019-2032
- 催產素市場 - 美國
- 催產素市場 - 加拿大
催產素市場 - 歐洲
- 歐洲：催產素市場，依通路劃分，2019-2032
- 歐洲：催產素市場，依適應症分類，2019-2032
- 催產素市場—英國
- 催產素市場—法國
- 催產素市場 - 德國
- 催產素市場 - 義大利
- 催產素市場 - 西班牙
- 催產素市場 - 荷蘭
- 催產素市場—俄羅斯
催產素市場－亞太地區
- 亞太地區：催產素市場，依通路劃分，2019-2032 年
- 亞太地區：催產素市場，依適應症分類，2019-2032 年
- 催產素市場 - 中國
- 印度催產素市場
- 馬來西亞催產素市場
- 催產素市場 - 日本
- 催產素市場-印尼
- 韓國催產素市場
催產素市場 - 中東和非洲
- 中東和非洲：催產素市場，依分銷管道劃分，2019-2032 年
- 中東與非洲：催產素市場，依適應症劃分，2019-2032 年
- 催產素市場-沙烏地阿拉伯
- 催產素市場 - 阿聯酋
- 催產素市場 - 以色列
- 催產素市場—南非
催產素市場 - 拉丁美洲
- 拉丁美洲：催產素市場，依通路劃分，2019-2032 年
- 拉丁美洲：催產素市場，依適應症分類，2019-2032 年
- 催產素市場 - 墨西哥
- 催產素市場 - 巴西
- 催產素市場 - 阿根廷

第八章競爭格局

擴張和收購分析
- 擴張
- 獲得
合作/協作/合約/展覽

第九章公司簡介

Pfizer Inc
Novartis AG
Ferring B.V
Fresenius Kabi LLC
Hikma Pharmaceuticals PLC
Endo International plc.（Par Sterile Products, LLC）
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Wockhardt Ltd.
Sun Pharmaceutical Industries Ltd
Yuhan Corporation

簡介目錄圖表

Product Code: PM4789

The global oxytocin market size is expected to reach USD 193.02 million by 2032, according to a new study by Polaris Market Research. The report "Oxytocin Market Share, Size, Trends, Industry Analysis Report, By Indication (Antepartum, Postpartum), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market is experiencing growth driven by increasing initiatives in maternal healthcare, which prioritize safe and effective obstetric care. Oxytocin, essential for labor induction and managing postpartum haemorrhage, plays a pivotal role in maternal healthcare. Efforts to decrease maternal mortality rates, enhance access to quality healthcare, and improve obstetric practices contribute to the rising demand for oxytocin injections. Additionally, endeavors to ensure the availability of essential medicines in maternal health programs are propelling the market, underscoring oxytocin's crucial role in enhancing maternal outcomes and overall obstetric care, particularly in regions facing significant maternal healthcare challenges.

The increasing prevalence of cesarean section deliveries is propelling the market, as oxytocin plays a critical role in enhancing or initiating labor during scheduled and emergency cesarean sections. With a growing number of cesarean deliveries worldwide, the need for oxytocin injections for labor enhancement or post-surgery uterine contraction is escalating. Oxytocin is vital for preventing postpartum haemorrhage and facilitating safe deliveries during cesarean sections.

Oxytocin serves as a crucial intervention in preventing & managing PPH, a primary cause of mortality. Awareness among the healthcare providers & policymakers regarding the life-saving impact of the oxytocin injections in controlling the excessive bleeding. Maternal health programs, campaigns, & health initiatives that emphasize the importance of PPH prevention further stimulate the adoption of oxytocin injections. Healthcare systems helps in reducing the mortality rates, owing to the oxytocin role in preventing the PPH.

Oxytocin Market Report Highlights

Postpartum segment garnered the largest share, owing to rise in maternal mortalities and concerned complications

Hospital segment dominated the market, as they are fully equipped with all medical facilities

APAC will grow at the fastest rate, owing to rise in child births and awareness regarding maternal health

The key market players include Pfizer, Novartis, Ferring, Fresenius Kabi, Hikma Pharmaceuticals, Endo International, Sun Pharmaceutical and Yuhan Corporation

Polaris Market Research has segmented the oxytocin market report based on indication, distribution channel, and region:

Oxytocin, Indication Outlook (Revenue - USD Million, 2019 - 2032)

Antepartum
Postpartum

Oxytocin, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

Hospital Pharmacies
Drug Stores
Online Pharmacies

Oxytocin, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of APAC
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of MEA

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Oxytocin Market Insights

4.1. Oxytocin Market - Industry Snapshot
4.2. Oxytocin Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rise in abortion and unwanted pregnancies
  - 4.2.1.2. Rise in cesarean deliveries
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Stringent regulations impacting market access and growth
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Oxytocin Industry trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Oxytocin Market, by Indication

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Oxytocin, by Indication, 2019-2032 (USD Million)
5.3. Antepartum
- 5.3.1. Global Oxytocin Market, by Antepartum, by Region, 2019-2032 (USD Million)
5.4. Postpartum
- 5.4.1. Global Oxytocin Market, by Postpartum, by Region, 2019-2032 (USD Million)

6. Global Oxytocin Market, by Distribution Channel

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
6.3. Hospital Pharmacies
- 6.3.1. Global Oxytocin Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Million)
6.4. Drug Stores
- 6.4.1. Global Oxytocin Market, by Drug Stores, by Region, 2019-2032 (USD Million)
6.5. Online Pharmacies
- 6.5.1. Global Oxytocin Market, by Online Pharmacies, by Region, 2019-2032 (USD Million)

7. Global Oxytocin Market, by Geography

7.1. Key findings
7.2. Introduction
- 7.2.1. Oxytocin Market Assessment, By Geography, 2019-2032 (USD Million)
7.3. Oxytocin Market - North America
- 7.3.1. North America: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.3.2. North America: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.3.3. Oxytocin Market - U.S.
  - 7.3.3.1. U.S.: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.3.3.2. U.S.: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.3.4. Oxytocin Market - Canada
  - 7.3.4.1. Canada: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.3.4.2. Canada: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.4. Oxytocin Market - Europe
- 7.4.1. Europe: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.4.2. Europe: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.4.3. Oxytocin Market - UK
  - 7.4.3.1. UK: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.4.3.2. UK: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.4.4. Oxytocin Market - France
  - 7.4.4.1. France: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.4.4.2. France: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.4.5. Oxytocin Market - Germany
  - 7.4.5.1. Germany: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.4.5.2. Germany: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.4.6. Oxytocin Market - Italy
  - 7.4.6.1. Italy: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.4.6.2. Italy: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.4.7. Oxytocin Market - Spain
  - 7.4.7.1. Spain: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.4.7.2. Spain: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.4.8. Oxytocin Market - Netherlands
  - 7.4.8.1. Netherlands: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.4.8.2. Netherlands: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.4.9. Oxytocin Market - Russia
  - 7.4.9.1. Russia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.4.9.2. Russia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.5. Oxytocin Market - Asia Pacific
- 7.5.1. Asia Pacific: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.5.2. Asia Pacific: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.5.3. Oxytocin Market - China
  - 7.5.3.1. China: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.5.3.2. China: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.5.4. Oxytocin Market - India
  - 7.5.4.1. India: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.5.4.2. India: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.5.5. Oxytocin Market - Malaysia
  - 7.5.5.1. Malaysia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.5.5.2. Malaysia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.5.6. Oxytocin Market - Japan
  - 7.5.6.1. Japan: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.5.6.2. Japan: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.5.7. Oxytocin Market - Indonesia
  - 7.5.7.1. Indonesia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.5.7.2. Indonesia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.5.8. Oxytocin Market - South Korea
  - 7.5.8.1. South Korea: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.5.8.2. South Korea: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.6. Oxytocin Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.6.2. Middle East & Africa: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.6.3. Oxytocin Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.6.3.2. Saudi Arabia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.6.4. Oxytocin Market - UAE
  - 7.6.4.1. UAE: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.6.4.2. UAE: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.6.5. Oxytocin Market - Israel
  - 7.6.5.1. Israel: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.6.5.2. Israel: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.6.6. Oxytocin Market - South Africa
  - 7.6.6.1. South Africa: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.6.6.2. South Africa: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.7. Oxytocin Market - Latin America
- 7.7.1. Latin America: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.7.2. Latin America: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.7.3. Oxytocin Market - Mexico
  - 7.7.3.1. Mexico: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.7.3.2. Mexico: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.7.4. Oxytocin Market - Brazil
  - 7.7.4.1. Brazil: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.7.4.2. Brazil: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.7.5. Oxytocin Market - Argentina
  - 7.7.5.1. Argentina: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  - 7.7.5.2. Argentina: Oxytocin Market, by Indication, 2019-2032 (USD Million)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Pfizer Inc
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. Novartis AG
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Ferring B.V
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Fresenius Kabi LLC
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. Hikma Pharmaceuticals PLC
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. Endo International plc. (Par Sterile Products, LLC)
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Teva Pharmaceutical Industries Ltd.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Mylan N.V.
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Wockhardt Ltd.
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Sun Pharmaceutical Industries Ltd
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
9.11. Yuhan Corporation
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development

簡介目錄圖表

List of Tables

Table 1 Global Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 2 Global Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 3 Oxytocin Market Assessment, By Geography, 2019-2032 (USD Million)
Table 4 North America: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 5 North America: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 6 U.S.: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 7 U.S.: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 8 Canada: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 9 Canada: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 10 Europe: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 11 Europe: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 12 UK: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 13 UK: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 14 France: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 15 France: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 16 Germany: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 17 Germany: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 18 Italy: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 19 Italy: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 20 Spain: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 21 Spain: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 22 Netherlands: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 23 Netherlands: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 24 Russia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 25 Russia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 26 Asia Pacific: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 27 Asia Pacific: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 28 China: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 29 China: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 30 India: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 31 India: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 32 Malaysia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 33 Malaysia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 34 Japan: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 35 Japan: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 36 Indonesia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 37 Indonesia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 38 South Korea: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 39 South Korea: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 40 Middle East & Africa: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 41 Middle East & Africa: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 42 Saudi Arabia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 43 Saudi Arabia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 44 UAE: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 45 UAE: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 46 Israel: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 47 Israel: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 48 South Africa: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 49 South Africa: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 50 Latin America: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 51 Latin America: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 52 Mexico: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 53 Mexico: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 54 Brazil: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 55 Brazil: Oxytocin Market, by Indication, 2019-2032 (USD Million)
Table 56 Argentina: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
Table 57 Argentina: Oxytocin Market, by Indication, 2019-2032 (USD Million)

List of Figures

Figure 1 Global Oxytocin Market, 2019-2032 (USD Million)
Figure 2 Integrated Ecosystem
Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
Figure 4 Market by Geography
Figure 5 Porter's Five Forces
Figure 6 Market by Distribution Channel
Figure 7 Global Oxytocin Market, by Distribution Channel, 2022 & 2032 (USD Million)
Figure 8 Market by Indication
Figure 9 Global Oxytocin Market, by Indication, 2022 & 2032 (USD Million)
Figure 10 Oxytocin Market Assessment, By Geography, 2019-2032 (USD Million)
Figure 11 Strategic Analysis - Oxytocin Market